METHOD FOR PREDICTING RESPONSIVENESS TO A PHARMACEUTICAL THERAPY FOR OBESITY

摘要

Methods for using TRL V6 as a biomarker for the modulation of triglycerideand/or lipoprotein metabolism in amammal induced by a weight loss pharmaceutical agent. The biomarker may beused for determining if an individual patient willlikely respond favorably to a given weight loss pharmaceutical agent.